ATE390436T1 - Verbesserter zerfall und rückfaltung von proteinen mittels hohen drucks - Google Patents

Verbesserter zerfall und rückfaltung von proteinen mittels hohen drucks

Info

Publication number
ATE390436T1
ATE390436T1 AT01270119T AT01270119T ATE390436T1 AT E390436 T1 ATE390436 T1 AT E390436T1 AT 01270119 T AT01270119 T AT 01270119T AT 01270119 T AT01270119 T AT 01270119T AT E390436 T1 ATE390436 T1 AT E390436T1
Authority
AT
Austria
Prior art keywords
refolding
high pressure
proteins
improved decay
present
Prior art date
Application number
AT01270119T
Other languages
English (en)
Inventor
Theodore Randolph
John Carpenter
John Richard St
Jonathan Webb
Original Assignee
Barofold Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Barofold Inc filed Critical Barofold Inc
Application granted granted Critical
Publication of ATE390436T1 publication Critical patent/ATE390436T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/57IFN-gamma
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462Lysozyme (3.2.1.17)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Disintegrating Or Milling (AREA)
  • Processing Of Solid Wastes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • External Artificial Organs (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT01270119T 2000-10-31 2001-10-31 Verbesserter zerfall und rückfaltung von proteinen mittels hohen drucks ATE390436T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24480800P 2000-10-31 2000-10-31

Publications (1)

Publication Number Publication Date
ATE390436T1 true ATE390436T1 (de) 2008-04-15

Family

ID=22924182

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01270119T ATE390436T1 (de) 2000-10-31 2001-10-31 Verbesserter zerfall und rückfaltung von proteinen mittels hohen drucks

Country Status (9)

Country Link
US (2) US7538198B2 (de)
EP (1) EP1434789B1 (de)
JP (3) JP2004530651A (de)
AT (1) ATE390436T1 (de)
CA (1) CA2434045A1 (de)
DE (1) DE60133426T2 (de)
DK (1) DK1434789T3 (de)
MX (1) MXPA03003867A (de)
WO (1) WO2002062827A2 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE349460T1 (de) 1998-07-09 2007-01-15 Barofold Inc Rückfaltung von protein-aggregaten und einschlussteilchen durch hohen druck
US7615617B2 (en) 1999-10-25 2009-11-10 University Of Delaware Use of hydrostatic pressure to inhibit and reverse protein aggregation and facilitate protein refolding
MXPA03003867A (es) 2000-10-31 2004-10-15 Univ Colorado Regents Desagregacion mejorada de proteina y replegamiento utilizando alta presion.
US7045297B2 (en) * 2001-11-14 2006-05-16 Prion Developmental Laboratories, Inc. Rapid prion-detection assay
US7614958B2 (en) * 2001-11-16 2009-11-10 Creative Kingdoms, Llc Interactive quest game
WO2006053251A2 (en) * 2004-11-12 2006-05-18 Pfizer, Inc. Method of measuring amyloid-beta peptides
EP1910415A4 (de) * 2005-07-25 2010-08-11 Trubion Pharmaceuticals Inc Zusammensetzungen und verfahren zur proteindeaggregation
CA2915270C (en) * 2005-08-05 2017-07-11 Amgen Inc. Stable aqueous protein or antibody pharmaceutical formulations and their preparation
KR20080080129A (ko) * 2005-11-21 2008-09-02 바로폴드, 인코포레이티드 단백질의 고압 리폴딩을 위한 장치 및 방법
EP2059523A2 (de) * 2006-09-15 2009-05-20 Barofold, Inc. Hochdruckbehandlung von proteinen für reduzierte immunogenizität
WO2008124139A1 (en) * 2007-04-05 2008-10-16 Barofold, Inc. High pressure inclusion body solubilization in the presence of a protease
JPWO2008133141A1 (ja) * 2007-04-24 2010-07-22 東洋紡績株式会社 オスモチン組換えタンパク質およびその製造方法、並びにその利用
CN101820966B (zh) * 2007-06-04 2017-10-27 高压生物科学公司 分子的压力提高的提取和分配
WO2009035617A1 (en) 2007-09-10 2009-03-19 Barofold, Inc. High-pressure refolding of monoclonal antibody aggregates
WO2009045553A1 (en) * 2007-10-05 2009-04-09 Barofold, Inc. High pressure treatment of aggregated interferons
EP2232235A2 (de) * 2007-12-10 2010-09-29 Novartis AG Analyse von proteine enthaltenden gemischen
WO2009137695A2 (en) * 2008-05-07 2009-11-12 Pressure Biosciences Inc. Extraction of biomolecular complexes assisted by alternating hydrostatic pressure
US8288122B2 (en) * 2008-12-03 2012-10-16 The United States Of America As Represented By The Department Of Veterans Affairs Pressure-assisted molecular recovery (PAMR) of biomolecules, pressure-assisted antigen retrieval (PAAR), and pressure-assisted tissue histology (PATH)
US8697848B2 (en) 2010-07-19 2014-04-15 The Regents Of The University Of Colorado Method for reducing immunogenicity of therapeutic protein compositions
US9797871B2 (en) 2010-08-05 2017-10-24 Ge Healthcare Bio-Sciences Ab Method for storage and stabilization of a target substance
US9995661B2 (en) 2010-08-18 2018-06-12 Pressure Biosciences, Inc. Flow-through high hydrostatic pressure microfluidic sample preparation device and related methods therefor
EP2632594A1 (de) 2010-10-28 2013-09-04 Edmund Y. Ting System und verfahren zur unterdrucksetzung von mikroplatten
EP2785196B1 (de) * 2011-12-01 2020-08-05 Pressure BioSciences, Inc. Verfahren und systeme zur proteinrückfaltung
CA2883296A1 (en) * 2012-08-30 2014-03-06 Merial, Inc. Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins
ZA201501696B (en) 2012-08-30 2016-01-27 Merial Ltd Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins
JP2014113108A (ja) * 2012-12-11 2014-06-26 Tokyo Medical Univ タンパク質の可溶化活性を有する多量体タンパク質およびその用途
EP2978770B1 (de) 2013-03-29 2019-11-06 Dr. Reddy's Laboratories Limited Rückfaltung von proteinen
WO2015034915A1 (en) * 2013-09-04 2015-03-12 The Regents Of The University Of California Method for improving protein functionality using vortexing fluid shear forces
EP2975120A1 (de) * 2014-07-17 2016-01-20 Institut Pasteur Monomeres und funktionelles Adenylatcyclase-CyaA-Toxin
AU2015294389B2 (en) 2014-07-24 2021-04-29 Genentech, Inc. Methods of conjugating an agent to a thiol moiety in a protein that contains at least one trisulfide bond
JPWO2017094722A1 (ja) * 2015-12-01 2018-10-11 Spiber株式会社 タンパク質溶液を製造する方法
JP2020152644A (ja) * 2019-03-18 2020-09-24 国立大学法人愛媛大学 Vnarのリフォールディング方法およびvnarの製造方法
KR20220079572A (ko) * 2019-09-20 2022-06-13 플라즈마 테크놀로지스, 엘엘씨 치료 단백질 조성물 및 방법(therapeutic protein compositions and methods)
CN114015758B (zh) * 2021-10-15 2022-06-24 无锡百泰克生物技术有限公司 一种冻干保护剂、荧光pcr检测试剂盒及冻干工艺
WO2024030679A1 (en) * 2022-08-05 2024-02-08 University Of Delaware System and apparatus for measuring scattered light signals from pressurized solutions and method of assembly

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064192A (en) * 1971-02-24 1977-12-20 Rhone-Poulenc S.A. Heat-stable polyimide resins
US4234620A (en) * 1978-12-26 1980-11-18 A. E. Staley Manufacturing Company Water-soluble vegetable protein aggregates
US4652630A (en) 1985-02-22 1987-03-24 Monsanto Company Method of somatotropin naturation
US4659568A (en) 1985-02-27 1987-04-21 American Cyanamid Company Process for solubilization, purification and characterization of protein from insoluble protein aggregates or complexes and compositions of matter therefrom
US4766224A (en) 1985-08-19 1988-08-23 International Minerals & Chemical Corp. Purification and activation of proteins from insoluble inclusion bodies
US4677196A (en) 1985-09-06 1987-06-30 International Minerals & Chemical Corp. Purification and activation of proteins from insoluble inclusion bodies
US5453363A (en) 1985-10-23 1995-09-26 Boehringer Mannheim Gmbh Process for the activation of t-PA or Ing after genetic expression in prokaryotes
US4929700A (en) 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
US5162507A (en) 1987-05-11 1992-11-10 Cetus Corporation Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
US4985544A (en) 1987-08-04 1991-01-15 Kyowa Hakko Kogyo Co., Ltd. Process for renaturing fish growth hormone
US4923967A (en) 1988-09-26 1990-05-08 Eli Lilly And Company Purification and refolding of recombinant proteins
DE3835350A1 (de) 1988-10-17 1990-04-19 Boehringer Mannheim Gmbh Aktivierung von gentechnologisch hergestellten, in prokaryonten exprimierten antikoerpern
US5064943A (en) 1988-12-16 1991-11-12 American Cyanamid Company Method for solubilization and naturation of somatotropin
GB8927008D0 (en) 1989-11-29 1990-01-17 Ciba Geigy Novel process for the production of unfused protein in e.coli
US5109117A (en) 1990-06-26 1992-04-28 Monsanto Company Method of somatotropin naturation using urea and a soluble organic alcohol
US5023323A (en) 1990-09-12 1991-06-11 Monsanto Company Method of somatotropin naturation
US5288931A (en) 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US5288462A (en) 1992-05-18 1994-02-22 Stephen D. Carter Sterilization apparatus and method
US5605691A (en) 1992-09-17 1997-02-25 Ophidian Pharmaceuticals, Inc. Immunologically active proteins from inclusion bodies
US5714371A (en) 1995-05-12 1998-02-03 Schering Corporation Method for refolding insoluble aggregates of hepatitis C virus protease
US5728804A (en) 1995-06-02 1998-03-17 Research Corporation Technologies, Inc. Use of cyclodextrins for protein renaturation
EP0924991B1 (de) * 1996-07-02 2001-10-04 BBI Bioseq, Inc. Druck-ermittelte bindung von biomolekularen komplexen
ATE349460T1 (de) * 1998-07-09 2007-01-15 Barofold Inc Rückfaltung von protein-aggregaten und einschlussteilchen durch hohen druck
US7615617B2 (en) 1999-10-25 2009-11-10 University Of Delaware Use of hydrostatic pressure to inhibit and reverse protein aggregation and facilitate protein refolding
MXPA03003867A (es) 2000-10-31 2004-10-15 Univ Colorado Regents Desagregacion mejorada de proteina y replegamiento utilizando alta presion.
KR20080080129A (ko) 2005-11-21 2008-09-02 바로폴드, 인코포레이티드 단백질의 고압 리폴딩을 위한 장치 및 방법
WO2008033555A2 (en) 2006-09-15 2008-03-20 Barofold, Inc. High-pressure refolding of difficult-to-fold proteins
EP2059523A2 (de) 2006-09-15 2009-05-20 Barofold, Inc. Hochdruckbehandlung von proteinen für reduzierte immunogenizität
WO2008124139A1 (en) * 2007-04-05 2008-10-16 Barofold, Inc. High pressure inclusion body solubilization in the presence of a protease

Also Published As

Publication number Publication date
MXPA03003867A (es) 2004-10-15
CA2434045A1 (en) 2002-08-15
EP1434789A2 (de) 2004-07-07
US20100075399A1 (en) 2010-03-25
WO2002062827A3 (en) 2004-05-06
DE60133426T2 (de) 2008-11-13
US8329878B2 (en) 2012-12-11
US7538198B2 (en) 2009-05-26
EP1434789B1 (de) 2008-03-26
US20040038333A1 (en) 2004-02-26
JP2008031182A (ja) 2008-02-14
JP2009102352A (ja) 2009-05-14
JP2004530651A (ja) 2004-10-07
DE60133426D1 (de) 2008-05-08
WO2002062827A2 (en) 2002-08-15
DK1434789T3 (da) 2008-07-07

Similar Documents

Publication Publication Date Title
ATE390436T1 (de) Verbesserter zerfall und rückfaltung von proteinen mittels hohen drucks
CY1119263T1 (el) Συνθεσεις και μεθοδοι για την αυξηση της ασβεστοποιησεως των οστων
ATE500323T1 (de) Subtilisin-variante
ATE368475T1 (de) Steigerung von durch antikörper-zytokin- fusionsproteine mediierten immunantworten durch eine kombinierte behandlung mit mitteln zur erhöhung der immunzytokinaufnahme
FR15C0003I2 (fr) Production de muteines recombinantes du facteur de coagulation sanguine viii dans des lignees de cellules humaines
DK1266025T3 (da) Protein-scaffolds for antistof-mimetika og andre bindingsproteiner
DK1233784T3 (da) Præparater og fremgangsmåder til stabilisering af biologiske molekyler efter lyofilisering
PL377553A1 (pl) Peptydy oraz pokrewne cząsteczki modulujące aktywność czynnika wzrostu nerwów
ATE466080T1 (de) Formulierungen und verfahren zum denaturieren von proteinen
ATE472334T1 (de) Polypeptidsequenzen, die an der modulation des immunsupppressiven effekts viraler proteine beteiligt sind
ATE477489T1 (de) Verfahren zur herstellung von protein expression arrays und anwendung derselben in schnellem screening
FR2857267B1 (fr) Formulation stabilisante et solubilisante pour les proteines cryoprecipitables.
AR042968A1 (es) Anticuerpos de virus anti-dengue composiciones metodos y usos
ATE439441T1 (de) Veränderte, fluoreszierende proteine
ATE412745T1 (de) Antiangiogene peptide vom n-terminus von endostatin
DE69838553D1 (de) Verfahren zur diagnose, prognose und behandlung von glaukom und verwandten erkrankungen
ATE476987T1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
DE60113535D1 (de) Kompositionen und verwendungen von cgi-69
DE60024977D1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
DE60109594D1 (de) R-eliprodil zur behandlung von glaucoma
ATE505538T1 (de) Dna-vektoren
DE60129228D1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide
ATE399019T1 (de) Verwendungen von tgap7 zur modulation der aktivierung von leukozyten
DE60120391D1 (de) Verwendung von hev-polypeptiden
ATE338063T1 (de) Diagnostische verwendungen des t-zell proteins tzon7, der davon abgeleiteten peptide und des antikörpers

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1434789

Country of ref document: EP

REN Ceased due to non-payment of the annual fee